2x Long Smci (SMCI) Share Price

Connections? Guys we have an insider on this board!! Yippee! Now I'm confident RNVA will make me a whole lot of moola! No sarcasm Thanks! DH

The list of available options for AVXL keeps getting shorter.

No new long term options have shown up.
Jan 16 2026 is the longest term option available.

but even at 72, I enjoy the thought of the bigger picture win.

I will be 78 in a few months, and even with third stage COPD, I eagerly embrace a path that does not involve quick money. It's beginning to look like AVXL may find itself in a truly unique position. Missling's has the ba

i fully trust him. i have been following him for a while.

In IQST We Trust🤠Hell yeah!!! 😀🙂💥😍

It would be unprecedented to have a halt on a pink sheet scam pending news, but besides that the volume is a debt rinse…especially the dummy that thinks there was a 70 million buy. Lol. The debt gets rinsed on both bid and ask clowns. The moronic ones on this site that count the tape are completely

Wishing criminal to be in prison isn’t wishing them bad it’s wishing justice to be rented!

Trump administration will bring justice and make America great again with the greatest transfer of wealth ever!

This month the Apes will go Apes as the Don appoint a new head for

FFIE: BIG NEWS - This Just In:

https://finance.yahoo.com/news/faraday-future-announce-fx-business-042500537.html

Well, it was an interesting year. Let us hope SDRC turns things around and starts actually mining to generate income, which will surely increase the stock price. Anything less will be a great disappointment to me.

Hell Yeah😃👍️ $1 soon.
$1 billion revenue company by 2027
____________________________________________

- For the nine months ending September 30, 2024,
iQSTEL's revenue skyrocketed to $184 million
nearly double last year's $97 million,

It's already starting again with FFIE

No need to hope. Hedge funds caused this. Massive short losses, not yet covered at those losses.

Massive gamma ramp could propel FFIE's price to $10+ as early as next week

Unfortunately scheduling a formal meeting with the FDA is a several moths long process.

With hopefully good fortune with respect to the EMA regulatory process, perhaps the FDA will find itself in a position where it be eager to expedite a review of Blarcamsine for AD in the U.S.

Wasn't he also taking tiger's blood?
Very relevant comment that illustrates the poor judgment capabilities of Charlie, who was a promoter of Leronlimab…

…yes this trash stock has attracted trash celebrities….not a surprise then that this stock has failed every rendez-vous with

Try and make that case to the SCOTUS!!

Try and make that case to the SCOTUS!!

I am not promoting a takeover, but I recognize it's eventually the most likely outcome. My strategy has been to accumulate enough stock so that I don't have to care too much which way the story goes.

Yes--a buyout is practically inevitable. That's why I have accumulated a lot of Janu

Do you have a cost comparison?


sure here you go

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175601250

the most insightful person on ihub has arrived, TrendTrade

Imo this is not fair to gbm patients but is how the fda as of now works exactly

I just told you that parrot

Inneresting idea: https://www.yahoo.com/news/dark-energy-may-not-exist-220018428.html

And flu news from eastern Pennsylvania, where Janice is prolly suffering from DaFlu (nott DaBirdFlu tho):

"Nationally, farmers have been forced to slaughter more than 100 million chic

The next wall will be the $4.50 , $5.50, $6.50 and so on😂

I can hope and dream to do the same thing as GameStop did back in the day and went up to $300 $400 $500 in two weeks. lol joking 

Ouch. Massive debt conversion gone bad. 2925 make the otc great again lol

I called on you Jimjet to simply label fact or conjecture next to each of the items that I posted. Almost every single item I posted was a fact. Yet you said that most of them were not.

You have refused to tell say which ones yiu think are facts and which are conjecture.